يحاول ذهب - حر
Making sure APIs made & controlled in consistent way
December 1-15, 2025
|Ingredients South Asia
THERE are a lot of rules, methods, and quality systems that make sure active pharmaceutical ingredients (APIs) are safe, effective, and meet international pharmacopeial and regulatory standards.
These rules are called Current Good Manufacturing Practices (cGMP). Because APIs have a direct impact on the safety and effectiveness of finished medical products given to patients, they need to be closely monitored for quality. APIs are the main active ingredients in pharmaceutical drugs.
An Overview of cGMP and Why It's Important in API Manufacturing:
The idea of "current" is part of cGMP, a new way of thinking about Good Manufacturing Practices (GMP) that focusses on using new technologies, scientific discoveries, and quality risk management methods. The main goal of cGMP is to set up a system that makes sure APIs are made and controlled in a consistent way that meets certain quality standards. This system also lowers the risks of contamination, mix-ups, and deviations during the manufacturing process.
Manufacturing under cGMP conditions covers every important step, from getting and handling raw materials and starting materials to synthesis, isolation, purification, and physical processing, as well as packing, labelling, storing, and shipping. It also includes intermediates and in-process quality control to make sure that the quality and safety profiles stay the same at all times.
Following cGMP makes sure that APIs meet the set standards for identification, purity, strength, and quality. All of these things are important for making sure that patients are safe and that the treatment works. The US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the World Health Organization (WHO), and the International Council for Harmonisation (ICH) have all made cGMP requirements official through guidance documents like ICH Q7, the FDA Code of Federal Regulations (21 CFR parts), and WHO GMP guidelines.
Important Parts of cGMP for APIs
1. Quality Management System (QMS)
هذه القصة من طبعة December 1-15, 2025 من Ingredients South Asia.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Ingredients South Asia
Ingredients South Asia
Conscious raises ₹15 cr in bridge round
D2C skincare brand Conscious Chemist, which is built on a singular mission to democratise science-backed, clinically proven skincare solutions for Indian consumers, has raised Rs 15 crore in a bridge round led by Atomic Capital.
2 mins
December 16-31, 2025
Ingredients South Asia
Innovation propelled by incorporation of fine chemicals & botanicals
INNOVATION in health and wellbeing is being propelled by the incorporation of fine chemicals and botanicals into nutraceuticals.
4 mins
December 16-31, 2025
Ingredients South Asia
PLI scheme resulted in cumulative sales of ₹2,315 cr: Ministry
THE production linked incentive (PLI) schemes for bulk drugs has resulted in cumulative sales of Rs. 2,315.44 crore, reducing imports worth Rs. 1,807.32 crore till September, 2025, according to the ministry of chemicals and fertilisers.
2 mins
December 16-31, 2025
Ingredients South Asia
Import of bulk drugs down 11% in Oct
IMPORTS of bulk drugs and intermediates to India registered a decline of 11.14% in the month of October, 2025, while the quantity of imports grew 20.74% during the month as compared to the same period of previous year.
1 mins
December 16-31, 2025
Ingredients South Asia
Herbal cosmetics safer, have fewer side-effects
COSMETICS are things that are meant to be rubbed, poured, sprinkled, sprayed, or put on the body or any part of it to clean, improve beauty, make it more attractive, or change its look, according to the Drugs and Cosmetics Act.
4 mins
December 16-31, 2025
Ingredients South Asia
COSME Week TOKYO to Present Complete Cosmetics Supply Chain and Global Networking Opportunities
COSME Week will spotlight the full spectrum of cosmetic innovation, highlighting developments from raw materials to finished products.
2 mins
December 16-31, 2025
Ingredients South Asia
Building a global footprint in silica-based solutions
FOR 17 years, Qingdao Bangkai has quietly grown into one of China’s most specialised manufacturers of silica-based inorganic materials—serving every major stage of the biopharma value chain.
2 mins
December 16-31, 2025
Ingredients South Asia
Ingestible beauty mirrors broader wellness movement
In Asia, radiant skin has long been linked to daily rituals, from layers of serums to jade rollers.
4 mins
December 16-31, 2025
Ingredients South Asia
The impact of tariff volatility on startups
India's pharmaceutical industry, often hailed as the “pharmacy of the world,” has long been a cornerstone of global healthcare, supplying affordable generic medicines to over 200 countries.
3 mins
December 16-31, 2025
Ingredients South Asia
Gender-neutral cosmetics now std expectations
BEAUTY plays a vital role in the overall well-being and self-esteem of individuals.
4 mins
December 16-31, 2025
Listen
Translate
Change font size
